Isomorphic Labs
Emily Boyce is an experienced professional in business and corporate development, currently serving as Business Development Manager at Isomorphic Labs since October 2024. Previously, Emily held various positions at Healx from December 2021 to September 2024, including Associate Director of Business and Corporate Development and Business Development Manager. A background in Deloitte from October 2018 to November 2021 involved roles such as Manager in Life Sciences, AI and Data, and Senior Consultant in Analytics & Cognitive and Risk Analytics. Earlier experience includes a Business Analyst position at GSK supporting clinical functions and participating in the R&D Tech Future Leader Program, along with a role as Business Intelligence Officer at Durbin PLC. Emily holds a Bachelor's degree in Biomedical Sciences from Imperial College London, completed in 2015.
This person is not in any teams
This person is not in any offices
Isomorphic Labs
7 followers
Isomorphic Labs is a new Alphabet company and commercial venture which aims to reimagine the entire drug discovery process from first principles with an AI-first approach, and, ultimately, to model and understand some of the fundamental mechanisms of life. Using computational advances, we’re working at the cutting edge in the new era of ‘digital biology’. By significantly increasing the pace of scientific research and efficacy of new medicines, we will be at the forefront of breakthroughs that will benefit millions of people.